'Acute coronary' presentation slideshows

HIGH SENSITIVITY C-REACTIVE PROTEIN IN CARDIOVASCULAR DISEASE AND MORTALITY

HIGH SENSITIVITY C-REACTIVE PROTEIN IN CARDIOVASCULAR DISEASE AND MORTALITY. Gary A. Lopez, M.D . Makati Medical Center Asian Hospital and Medical Center. Cardiovascular disease is the most frequent cause of mortality in the Philippines , the U.S., and many parts of the world.

761 views • 68 slides

HIGH SENSITIVITY C-REACTIVE PROTEIN IN CARDIOVASCULAR DISEASE AND MORTALITY

HIGH SENSITIVITY C-REACTIVE PROTEIN IN CARDIOVASCULAR DISEASE AND MORTALITY. Gary A. Lopez, M.D . Makati Medical Center Asian Hospital and Medical Center. Cardiovascular disease is the most frequent cause of mortality in the Philippines , the U.S., and many parts of the world.

767 views • 68 slides

Management of Hypertension according to JNC 7

Management of Hypertension according to JNC 7. BY SANDAR KYI, MD. Introduction.

755 views • 27 slides

Guidelines Applied to Practice (GAP)

Guidelines Applied to Practice (GAP). American College of Cardiology, Puerto Rico Chapter. Guidelines Applied in Practice (GAP). INTRODUCTION. Chronic Coronary Syndromes (Chronic Stable Angina). San Juan : Hotel Intercontinental, Feb. 6, 2007 - Jorge Ortega Gil, MD

489 views • 27 slides

Pathophysiology & Clinical Presentations

Pathophysiology & Clinical Presentations. Acute Coronary Syndromes. 1. Ischemic Heart Disease - Overview. Parameters Anatomy: Atheroma / Atherothrombosis Subjective: Angina Objective: EKG T wave ST seg changes

418 views • 25 slides

Pathophysiology & Clinical Presentations

486 views • 25 slides

Rationale for Study

Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?.

179 views • 16 slides

US Cardiac Biomarker Market: Industry Growth, Market Size, Share and Forecast 2019-2025

The US Cardiac Biomarker Market is estimated to grow significantly at a CAGR of 7.2% during the forecast period. The major factors that propel the market growth include the high prevalence of CVDs and heart related diseases in the country coupled with robust healthcare expenditure.

43 views • 4 slides